Partner. Advocate. Friend. At the MPN Research Foundation, we’re committed to standing with you in the fight against polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF) – the group of blood cancers collectively known as myeloproliferative neoplasms.
A recent article titled "A knockout Combination for MPN Stem Cells" was published in the Journal of Experimental Medicine and is partially funded by MPNRF and our supporters through the Interferon Initiative.
Read MoreHelp Advance MPN Research from Home and Earn $50
Read MorePMF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.
Learn about PMFMost commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.
Learn about ETThe disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.
Learn about PVJuan Alderete, PV 06
By supporting MPN Research Foundation, you're also supporting countless doctors and researchers around the world who are working to find a cure for these rare diseases.
A safe space to chat with others living with PV, ET and MF
Start here!
Be the first to know about what's going on in the PV, ET, and MF community.
Get the Kit